IFF Stock Recent News
IFF LATEST HEADLINES
International Flavors (IFF) agrees to sell its Pharma Solutions business, thus marking another step in its portfolio optimization strategy.
International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.
International Flavors expects 2024 revenue of between $10.8 billion and $11.1 billion, below analysts' consensus.
The headline numbers for International Flavors (IFF) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
International Flavors' (IFF) Q4 results are likely to reflect the impacts of lower volumes and escalating costs.
Besides Wall Street's top -and-bottom-line estimates for International Flavors (IFF), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
International Flavors (IFF) closed the most recent trading day at $80.49, moving +0.21% from the previous trading session.
International Flavors (IFF) reachead $80.18 at the closing of the latest trading day, reflecting a -1.34% change compared to its last close.
In the most recent trading session, International Flavors (IFF) closed at $82.01, indicating a -0.3% shift from the previous trading day.
Companies with unique competitive advantages aren't always rewarded by the market: Etsy Inc. NASADQ: ETSY, International Flavors & Fragrances Inc. NYSE: IFF and Zimmer Biomet Holdings Inc. NYSE: ZBH are examples of stocks that appear to be trading well below their intrinsic value, based on earnings projections.